SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-020431
Filing Date
2021-08-17
Accepted
2021-08-17 15:43:37
Documents
14
Period of Report
2021-08-17
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42327
2 ex99-1.htm EX-99.1 13883
3 form8k_001.jpg GRAPHIC 4560
  Complete submission text file 0001493152-21-020431.txt   241085

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cqen-20210817.xsd EX-101.SCH 3027
5 XBRL LABEL FILE cqen-20210817_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE cqen-20210817_pre.xml EX-101.PRE 22360
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3285
Mailing Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419
Business Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419 612-812-2037
CQENS Technologies Inc. (Filer) CIK: 0001479915 (see all company filings)

IRS No.: 271521364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55470 | Film No.: 211182638
SIC: 2834 Pharmaceutical Preparations